Emily Field

Stock Analyst at Barclays

(2.66)

# 2,097

Out of 4,749 analysts

6

Total ratings

100%

Success rate

13.57%

Average return

Main Sectors:

Top Industries:

Biotechnology Drug Manufacturers - General

Stocks Rated by Emily Field

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	GLPG Galapagos NV	Downgrades: Underweight	n/a	$23.00	-	1	Jan 23, 2025
	GSK GSK	Upgrades: Equal-Weight	n/a	$35.27	-	4	Nov 5, 2021
	ARGX argenx SE	Upgrades: Overweight	n/a	$655.13	-	1	Oct 19, 2021

Galapagos NV

Jan 23, 2025

Downgrades: Underweight

Price Target: n/a

Current: $23.00

Upside: -

GSK

Nov 5, 2021

Upgrades: Equal-Weight

Price Target: n/a

Current: $35.27

Upside: -

argenx SE

Oct 19, 2021

Upgrades: Overweight

Price Target: n/a

Current: $655.13

Upside: -